VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 59 of Oncotarget features Figure 4, "The expression of AGR2 in metastatic lesions," by Kamal, et al.
|
|
Table of Contents
Research Papers
|
| Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing |
|
https://doi.org/10.18632/oncotarget.25764
|
| 31312-31329 |
|
| Association of Notch1 osteopontin and stemlike cells in ENUglioma malignant process |
|
https://doi.org/10.18632/oncotarget.25808
|
| 31330-31341 |
|
| A shortchain fatty acid propionate enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells |
|
https://doi.org/10.18632/oncotarget.25809
|
| 31342-31354 |
|
| Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgicallyinduced endometriosis |
|
https://doi.org/10.18632/oncotarget.25823
|
| 31355-31366 |
|
| STK405759 as a combination therapy with bortezomib or dexamethasone in in vitro and in vivo multiple myeloma models |
|
https://doi.org/10.18632/oncotarget.25825
|
| 31367-31379 |
|
| Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3 |
|
https://doi.org/10.18632/oncotarget.25826
|
| 31380-31396 |
|
| The combination of epigenetic drugs SAHA and HCI2509 synergistically inhibits EWSFLI1 and tumor growth in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.25829
|
| 31397-31410 |
|
| Topoisomerase I inhibitor irinotecan depletes regulatory T cells and upregulates MHC class I and PDL1 expression resulting in a supraadditive antitumor effect when combined with antiPDL1 antibodies |
|
https://doi.org/10.18632/oncotarget.25830
|
| 31411-31421 |
|
| Development and evaluation of a novel antibodyphoton absorber conjugate reveals the possibility of photoimmunotherapyinduced vascular occlusion during treatment in vivo |
|
https://doi.org/10.18632/oncotarget.25831
|
| 31422-31431 |
|
| CCL17/TARC and CCR4 expression in Merkel cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25836
|
| 31432-31447 |
|
| Identification of a novel HLAA24restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.25837
|
| 31448-31458 |
|
| High AGR2 protein is a feature of low grade endometrial cancer cells |
|
https://doi.org/10.18632/oncotarget.25838
|
| 31459-31472 |
|
| Combination of electroporation delivered metabolic modulators with lowdose chemotherapy in osteosarcoma |
|
https://doi.org/10.18632/oncotarget.25843
|
| 31473-31489 |
|
| Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T |
|
https://doi.org/10.18632/oncotarget.25844
|
| 31490-31501 |
|
| Molecular profiling of colorectal tumors stratified by the histological tumorstroma ratio Increased expression of galectin1 in tumors with high stromal content |
|
https://doi.org/10.18632/oncotarget.25845
|
| 31502-31515 |
|
| Interaction between Ncadherin and decoy receptor2 regulates apoptosis in head and neck cancer |
|
https://doi.org/10.18632/oncotarget.25846
|
| 31516-31530 |
|
| The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting CRAF for degradation |
|
https://doi.org/10.18632/oncotarget.25847
|
| 31531-31548 |
|
| Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells |
|
https://doi.org/10.18632/oncotarget.25862
|
| 31549-31558 |
Corrections
|
| Correction: S100A9+ MDSC and TAMmediated EGFRTKI resistance in lung adenocarcinoma: the role of RELB |
|
https://doi.org/10.18632/oncotarget.25943
|
| 31559-31559 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
